Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-15-000224
Filing Date
2015-01-23
Accepted
2015-01-23 16:15:43
Documents
1
Period of Report
2015-01-21

Document Format Files

Seq Description Document Type Size
1 c79928_4.html 4  
1 c79928_4.xml 4 3969
  Complete submission text file 0000930413-15-000224.txt   5170
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Issuer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
SIC: 8071 Services-Medical Laboratories

Mailing Address
Business Address
KASTEN BERNARD L (Reporting) CIK: 0001244745 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-09974 | Film No.: 15545744